Vir Biotechnology Inc (VIR)

Exchange
NASDAQ
Symbol
VIR
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The company is headquartered in San Francisco, California.
Country
USA

Stock price

At close: February 6, 2026

  • Open
    7.06
  • High
    7.40
  • Low
    7.04
  • Close
    7.19
  • Volume
    1,864,090

Financial ratios

Dec 31, 2024